We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.13%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$775M
AUM Growth
-$436M
Cap. Flow
-$471M
Cap. Flow %
-60.72%
Top 10 Hldgs %
18.21%
Holding
4,545
New
711
Increased
1,179
Reduced
1,568
Closed
1,030

Sector Composition

Rank Sector Weight
1 Financials 11.08%
2 Technology 10%
3 Consumer Discretionary 7.02%
4 Healthcare 6.86%
5 Communication Services 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YHGJ icon
3376
Yunhong Green CTI Ltd
YHGJ
$7.18M
$1K ﹤0.01%
+14
New +$546
ZDGE icon
3377
Zedge
ZDGE
$38.9M
$1K ﹤0.01%
240
NESR
3378
National Energy Services Reunited Corp
NESR
$2.9B
$1K ﹤0.01%
+85
New +$838
PHLT
3379
DELISTED
Performant Healthcare Inc
PHLT
$1K ﹤0.01%
808
-1,948
-71% -$3.51K
PDCO
3380
DELISTED
Patterson Companies, Inc.
PDCO
$1K ﹤0.01%
15
-4,608
-100% -$168K
AUMN
3381
DELISTED
Golden Minerals Company
AUMN
$1K ﹤0.01%
60
LUMO
3382
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$1K ﹤0.01%
8
-43
-84% -$3.56K
PIXY
3383
DELISTED
ShiftPixy, Inc. Common Stock
PIXY
0
CHS
3384
DELISTED
Chicos FAS, Inc.
CHS
$1K ﹤0.01%
165
-8,143
-98% -$67.7K
AEY
3385
DELISTED
ADDvantage Technologies Group
AEY
$1K ﹤0.01%
+57
New +$833
ACGN
3386
DELISTED
Aceragen Inc
ACGN
$1K ﹤0.01%
3
-87
-97% -$24.8K
NSL
3387
DELISTED
NUVEEN SENIOR INCM FD
NSL
$1K ﹤0.01%
200
-300
-60% -$1.98K
GER
3388
DELISTED
Goldman Sachs MLP Energy Renaissance Fund
GER
$1K ﹤0.01%
+11
New +$607
CSII
3389
DELISTED
Cardiovascular Systems, Inc.
CSII
$1K ﹤0.01%
39
-3,991
-99% -$101K
DTEA
3390
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
$1K ﹤0.01%
335
-1,112
-77% -$4.59K
NKG
3391
DELISTED
Nuveen Georgia Quality Municipal Income Fund
NKG
$1K ﹤0.01%
+117
New +$1.53K
AGRX
3392
DELISTED
Agile Therapeutics
AGRX
0
FSTX
3393
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$1K ﹤0.01%
19
-31
-62% -$1.84K
RADA
3394
DELISTED
Rada Electronic Industries Ltd
RADA
$1K ﹤0.01%
+413
New +$1.35K
GSV
3395
DELISTED
Gold Standard Ventures Corp.
GSV
$1K ﹤0.01%
+600
New +$916
VOLT
3396
DELISTED
Volt Information Sciences, Inc.
VOLT
$1K ﹤0.01%
356
ACBI
3397
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
$1K ﹤0.01%
59
-7,696
-99% -$133K
RRD
3398
DELISTED
RR Donnelley & Sons Co.
RRD
$1K ﹤0.01%
100
-4,102
-98% -$37.4K
GDP
3399
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
$1K ﹤0.01%
+100
New +$1.03K
IFMK
3400
DELISTED
iFresh Inc. Common Stock
IFMK
$1K ﹤0.01%
+100
New +$1.2K

Similar funds

Tower Research Capital (TRC)'s Q4 2017 Portfolio in Review

As of Q4 2017, Tower Research Capital (TRC) held 4,545 positions worth $775M, down 36% from $1.21B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Tower Research Capital (TRC) withdrew a net $471M in Q4 2017, closing 1,030 positions and reducing 1,568 holdings. Its most notable exit was iShares MSCI EAFE ETF, an estimated $25.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 6.3% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Berkshire Hathaway Class B worth $7.94M.

  • Tower Research Capital (TRC)'s largest Q4 2017 buy was Berkshire Hathaway Class B: 40,072 shares worth $7.94M.
  • Tower Research Capital (TRC) added most to Apple in Q4 2017, an estimated $8.74M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $223M.
  • Tower Research Capital (TRC) fully exited iShares MSCI EAFE ETF in Q4 2017, selling an estimated $25.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 18% of its $775M portfolio in Q4 2017.
  • Tower Research Capital (TRC) opened 711 new positions and closed 1,030 in Q4 2017.
  • Tower Research Capital (TRC)'s portfolio value fell 36% quarter-over-quarter to $775M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2017, filed 9 Feb 2018.